Navigation Links
Retina Specialty Institute Gives Patients Something to Look Forward to in Crestview
Date:1/20/2013

Crestview, FL (PRWEB) January 21, 2013

Retina Specialty Institute is opening a new office location in Crestview, Fla. to help treat patients suffering from Age-Related Macular Degeneration (AMD), Diabetic Retinopathy and other vision-threatening retinal diseases. Retina Specialty Institute is a national, FDA-approved clinical trial study center based out of Pensacola, Fla. with offices in Mississippi, Alabama and the Florida Gulf Coast.

“Many of our patients in the Crestview, Niceville and surrounding area have had to drive to our Pensacola or Fort Walton Beach offices in order to seek treatments,” said Sunil Gupta, M.D., founder of Retina Specialty Institute.

“This new location will offer patients in these areas accessibility to more convenient treatment that will best fit their personal, transportational and scheduling needs.“

The new office, opening January 18, 2013, is located at 1299 Industrial Drive, Crestview, FL 32539. Dr. Gupta, Dr. John Myers and Dr. Ryan Tarantola and their staff are currently accepting new appointments for patients seeking treatments.

For more information regarding the new office location, including office hours and scheduling appointments, call toll-free at 1-855-5RETINA.

Through its mission of preserving, treating and advancing the science of sight, Retina Specialty Institute offers national clinical trials and state-of-the art surgical skills to patients throughout the Southeast including Pensacola, Fla., Mobile, Ala., and Hattiesburg, Miss. For more information, visit http://www.retinaspecialty.com or to schedule an appointment, call 850-476-6759 or toll-free 866-293-8159.

# # #

Read the full story at http://www.prweb.com/releases/2013/1/prweb10335673.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Retinal Device Restores Sight to Blind Mice
2. Study finds novel therapy that may prevent damage to the retina in diabetic eye diseases
3. Prosthetic retina offers simple solution to restoring sight
4. New type of retinal prosthesis could better restore sight to blind, Stanford study says
5. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
6. Antibiotics Linked to Retinal Detachment Risk
7. Aesthetic Dermatology Specialty Centre Gets A Facelift
8. The JAMA Network announces new names, new embargo schedules for specialty journals
9. Leisure Fitness Opens 23rd Fitness Equipment Super Store in Paramus, NJ, Bringing Specialty Fitness Equipment and Health & Wellness to the New Jersey Fitness Community
10. Health reform: How community health centers could offer better access to subspecialty care
11. Ethics should drive health policy reform, especially with physician-owned specialty hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... detection methods that can rapidly screen a large ... cell inside that population has been seriously lacking," ... In the Royal Society of Chemistry journal ... and his coworkers have developed a novel technique ... ( Chem. Sci. , 2014, DOI: 10.1039/C4SC00578C, ...
(Date:4/23/2014)... in the popular Swedish children,s TV show Bolibompa, ... A new study from the University of Gothenburg ... programmes as well as the link between young ... , Steingerdur Olafsdottir,s doctoral thesis focuses on the ... TV show Bolibompa. Healthy foods dominated in the ...
(Date:4/23/2014)... team of scientists led by a researcher from the ... National University of Singapore has identified the cancer specific ... up the possibility of developing new drugs for the ... , The research group, led by Dr Chan Shing ... the first time that a cancer-specific variant of a ...
(Date:4/23/2014)... journal Oncotarget , explored tumour heterogeneity ... own DNA signatures within the same cancer. Such ... targeted treatment strategies. , Firstly they confirmed the ... the KRAS or BRAF mutation. Secondly, they found ... mutation have that specific mutation present uniformly throughout ...
(Date:4/23/2014)... to the bottom of Alzheimer,s disease has been ... and controversies. In the latest crook in the ... into the interaction between proteins associated with the ... ACS Chemical Neuroscience , could have important ... Surewicz, Krzysztof Nieznanski and colleagues explain that for ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
... Society of ... Surgeons Annual Meeting, BALTIMORE, Oct. 28 One facelift or ... In fact,plastic surgeons analyze facial features and configurations to,individualize results based ... at the American Society of Plastic Surgeons (ASPS) Plastic,Surgery 2007 conference ...
... Annual Meeting, BALTIMORE, Oct. 28 While the ... to for fear of sagging,breasts. However, breastfeeding alone has ... first-of-its-kind study presented today at the,American Society of Plastic ... women who come in for breast surgery tell us ...
... in which the bladder forms outside of the abdomen ... with the same condition, according to a small study ... The condition, known as bladder exstrophy, requires a series ... early adolescence.The findings are being reported at the American ...
... 2007 MedImmune, Inc. today announced it will present ... 2007 National Conference & Exhibition, adding to the companys ... syncytial virus (RSV), a leading cause of hospitalization among ... that provide key insights into how we can optimize ...
... connected, study finds , THURSDAY, Oct. 25 (HealthDay ... a follow-up osteoporosis management program that includes electronic ... , Osteoporosis -- which increases the risk of ... 65 and older. Medication can greatly reduce fracture ...
... American Red Cross,Blood Services national system continues to ship ... to help stabilize the blood,supply in the region affected ... provided nearly 2,000 blood products to date,in support of ... drives in southern California have been curtailed due to ...
Cached Medicine News:Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 2Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 3Health News:Breastfeeding Does Not Create Sagging Breasts; Study Throws Out Old Wives' Tale 2Health News:MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics 2Health News:Older Women Gain From Good Post-Fracture Care 2Health News:American Red Cross Blood Services Supports Blood Needs of Southern California 2
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 16, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical ... CMED ), a leading China-based ... its unaudited financial results for the ... 2011 ("1Q FY2011") today.1 Q ...
... More than a decade of targeted Muscular Dystrophy Association-funded ... support of the MDA Labor Day Telethon and thousands ... providing financial assistance for the start of the first ... pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, ...
Cached Medicine Technology:China Medical Technologies Reports First Fiscal Quarter Financial Results 2China Medical Technologies Reports First Fiscal Quarter Financial Results 3China Medical Technologies Reports First Fiscal Quarter Financial Results 4China Medical Technologies Reports First Fiscal Quarter Financial Results 5China Medical Technologies Reports First Fiscal Quarter Financial Results 6China Medical Technologies Reports First Fiscal Quarter Financial Results 7China Medical Technologies Reports First Fiscal Quarter Financial Results 8China Medical Technologies Reports First Fiscal Quarter Financial Results 9China Medical Technologies Reports First Fiscal Quarter Financial Results 10China Medical Technologies Reports First Fiscal Quarter Financial Results 11China Medical Technologies Reports First Fiscal Quarter Financial Results 12China Medical Technologies Reports First Fiscal Quarter Financial Results 13China Medical Technologies Reports First Fiscal Quarter Financial Results 14China Medical Technologies Reports First Fiscal Quarter Financial Results 15China Medical Technologies Reports First Fiscal Quarter Financial Results 16China Medical Technologies Reports First Fiscal Quarter Financial Results 17China Medical Technologies Reports First Fiscal Quarter Financial Results 18China Medical Technologies Reports First Fiscal Quarter Financial Results 19MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy 2MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy 3MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy 4
...
... System is your system. CONMED's family of ... specialty. New, state-of-the art generators feature proprietary ... a continuous synchronization of current and voltage ... architecture enables the system to sample current ...
... biologically based adhesive supplied as a ... of a liquid substrate and crosslinker ... bleeding. When combined the ... a prepared wound and tenaciously adhere ...
... DERMABOND* Topical Skin Adhesive gives you ... adhesive is intended for topical application only ... of wounds from surgical incisions, including punctures ... cleansed, trauma-induced lacerations. DERMABOND adhesive may be ...
Medicine Products: